August 11th, 2014
TapImmune, Inc. (the “Company”), (OTCQB:TPIV), today announced that it has entered into a definitive agreement with an institutional investor for a registered direct placement of $2,000,000 of common stock at a price of $1.06 per share.
In addition, the Company will issue to the investor warrants to purchase up to 1,886,793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance.
The offering is expected to close on or about August 14, 2014, subject to satisfaction of customary closing conditions.
H.C. Wainwright & Co., LLC, acted as the exclusive placement agent in connection with this offering.